Befoair

Befoair is a combination inhaler containing Beclometasone Dipropionate and Formoterol Fumarate Dihydrate, used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication helps control symptoms and improve breathing.

Befoair is primarily used for the maintenance treatment of asthma and COPD. The Beclometasone Dipropionate component reduces inflammation in the airways, while Formoterol Fumarate Dihydrate helps relax the muscles around the airways, making it easier to breathe. This combination is often prescribed to manage symptoms and prevent exacerbations.

Common effects of Befoair may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Befoair should be used as directed by a healthcare professional. It is important to rinse your mouth after each use to minimize the risk of throat irritation and fungal infections. Patients with certain medical conditions, such as heart disease or diabetes, should discuss the use of Befoair with their healthcare provider.

Befoair may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other inhalers should be discussed with a healthcare professional.